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Molecular techniques can often reveal a broader range of pathogens in respiratory infections.
We aim to investigate the prevalence and age pattern of viral co-infection in children hospital-
ized with lower tract acute respiratory infection (LT-ARI), using molecular techniques.
Methods
A nested polymerase chain reaction approach was used to detect Influenza (A, B), metap-
neumovirus, respiratory syncytial virus (RSV), parainfluenza (1–4), rhinovirus, adenovirus
(A—F), bocavirus and coronaviruses (NL63, 229E, OC43) in respiratory samples of children
with acute respiratory infection prospectively admitted to any of the GENDRES network
hospitals between 2011–2013. The results were corroborated in an independent cohort col-
lected in the UK.
Results
A total of 204 and 97 nasopharyngeal samples were collected in the GENDRES and UK
cohorts, respectively. In both cohorts, RSV was the most frequent pathogen (52.9% and
36.1% of the cohorts, respectively). Co-infection with multiple viruses was found in 92 sam-
ples (45.1%) and 29 samples (29.9%), respectively; this was most frequent in the 12–24
months age group. The most frequently observed co-infection patterns were RSV—
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Rhinovirus (23 patients, 11.3%, GENDRES cohort) and RSV—bocavirus / bocavirus—influ-
enza (5 patients, 5.2%, UK cohort).
Conclusion
The presence of more than one virus in pediatric patients admitted to hospital with LT-ARI is
very frequent and seems to peak at 12–24 months of age. The clinical significance of these
findings is unclear but should warrant further analysis.
Introduction
Lower tract acute respiratory infections (LT-ARI) are estimated to cause 75% of all acute ill-
nesses and are the leading cause of hospitalization for infants and young children worldwide
[1,2]. Most infections in children and adults are caused by viruses [1,3,4], including respiratory
syncytial virus (RSV), influenza virus (IV), human parainfluenza virus (hPIV), adenovirus
(AdV) and rhinovirus (hRV). In the past decade, several new respiratory viruses, including
human metapneumovirus (hMPV) [5], new subtypes of human coronaviruses (hCoV) [1] and
bocavirus (hBoV) [6], have been associated with LT-ARI, though their clinical importance
requires clarification. The frequency of LT-ARI cases varies with age, among other factors.
The wider availability of molecular diagnosis techniques has allowed the identification of
pathogens otherwise missed using conventional methods, and their use frequently leads to
detection of more than one microorganism [7]. The importance of viral co-infections in the
pathogenesis of LT-ARI is unclear; furthermore, the possible impact of age on viral co-infection
prevalence is, to the best of our knowledge, unknown.
In the present study we aimed to estimate the prevalence of viral co-infection in children
hospitalized with LT-ARI and to assess the impact of age in the rates of viral co-infection in
these children.
Material and Methods
Study design and recruitment criteria
We conducted an observational, prospective study in Spain through a national hospital-based
research network for pediatric respiratory research: GENDRES (Genetics, vitamin D and respi-
ratory infections research network– www.gendres.org), which includes 13 Spanish tertiary hos-
pitals. Eligible study participants were previously healthy children under 14 years of age
admitted to a participating hospital with an LT-ARI diagnosis. LT-ARI was defined as any
acute lower respiratory tract infection of sufficient severity to warrant admission to hospital.
All types of LT-ARI were included, from bronchiolitis to pneumonia, with or without wheez-
ing, fever, rhinorrhea or respiratory distress. A nasopharyngeal sample (aspirate/wash or swab)
was obtained during admission in patients recruited between January 2011 and January 2013.
A comparison cohort of 97 UK children admitted with LT-ARI, aged over 1 month, and sick
enough to warrant blood tests, was recruited between 2009 and 2012 as part of the Immunopa-
thology of Respiratory Infection Study (IRIS) at St Mary’s Hospital, London. These cohorts
allowed for comparison of North and South European data from two regions with different cli-
mate and healthcare systems, as well as permitting validation of the Spanish findings on co-
infection rate,and overall virus frequency. In both cohorts, recruited patients were admitted to
PICU or ward. The Spanish cohort study was approved by the Ethical Committee of Clinical
Viral Co-Infections in Children with Respiratory Infections
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Investigation of Galicia (CEIC ref 2010/015) and by the regional ethics committees for each
participating center, while the UK cohort study was approved by the St Mary’s Research Ethics
Committee (REC 09/H0712/58). Written informed consent was obtained from a parent or
legal guardian for each subject before study inclusion.
Laboratory methods
Nasopharyngeal samples were obtained using a sterile feeding tube and injector for nasopha-
ryngeal aspirate/wash or a sterile nylon swab without culture medium. Samples were kept at
4°C for up to 24 hours before storage at -80°C, pending transport on dry ice to the UK for virus
detection by multiplex nested polymerase chain reaction (PCR) for 19 viruses: RSV; IV (A, B);
HPIV types (1–4); AdV (A—F); hRV; HMPV; HCoV (NL63, 229E, OC43) and hBoV (gene
targets and primer sources in Table 1). At the time of processing, viral material was eluted into
a volume of 200 μl. Nucleic acid extracts were prepared using a QiagenMDx BioRobot. First
round amplification was performed using 20 μl nucleic acid extract. Second round PCR was
performed using 1 μl amplicon from first round PCR as template material. Reactions were run
using a Lightcycler 480 with melt curve analysis for the detection of PCR products. Genotyping
was performed by Sanger sequencing of second round PCR products when appropriate (AdV).
Sequences were analysed using the BLAST algorithm.
Data analysis
General data are shown as percentages or means with 95% confidence intervals (CI). Fisher’s
exact test was used to study the association between the viruses and PICU admission. The level
of statistical significance was set to 0.05. Statistical tests and Figures were carried out using R
software v. 3.0.2 (R Core Team (2013). R: A language and environment for statistical comput-
ing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL
http://www.R-project.org/http://www.r-project.org/).
Table 1. PCR gene targets and sources fromwhich the primers were obtained.
Virus Gene targets
Inﬂuenza A [8] Gene N
Inﬂuenza B [9] Gene M
Metapneumovirus [10] Gene N
RSV [11] Gene N
Parainﬂuenza 1 [8] Gene HN
Parainﬂuenza 2 [12] Gene HN
Parainﬂuenza 3 [12] Gene HN
Parainﬂuenza 4 [13] Gene P
Rhinovirus [14] 5’ UTR
Adenovirus (A-F) [15,16] Hexon
Bocavirus [17] NS encoding region
Coronavirus NL63 [18] Gene N
Coronavirus 229E [19] Gene M
Coronavirus OC43 [20] Gene N
This multiplex nested PCR was performed in all samples independently of any diagnostic test carried out
by the referring hospital.
doi:10.1371/journal.pone.0136526.t001
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Results
GENDRES cohort
The GENDRES cohort had a median age of 6.4 (first quartile: 2.2, third quartile:17.0) months
and a male-to-female sex ratio of 1.7. One patient was excluded due to incomplete clinical data.
The cohort included nasopharyngeal samples from 204 patients: 23 (11.3%) nasopharyngeal
swabs and 181 (88.7%) nasopharyngeal aspirates/wash. No differences in findings were
observed in relation to the method used for sample collection (data not shown).
Molecular diagnostics identified at least one pathogen in 187 samples. Of these PCR positive
samples, 73 had previously yielded negative results using conventional methodology—immu-
nufluorescence assays and/or rapid techniques. Five samples (2.5%) were negative for both
PCR and the initial diagnostic work-up. In 12 cases (5.9%) where the referring hospital had
established a diagnosis, PCR was negative (RSV, n = 8; IV H1N1, n = 2; Mycoplasma, n = 1;
and Influenza C, n = 1). By PCR multiplex assay, a single pathogen was detected in 95 (46.6%)
children and two or more pathogens were detected in 92 (45.1%) patients, giving an overall
detection rate of 91.7%. The most commonly detected virus was RSV (n = 108), followed by
hRV (n = 68), hBoV (n = 48), AdV (n = 39), HMPV (n = 27), IV (n = 12), hPIV and hCoV
(both n = 5) (Table 2). In co-infected samples, the most frequent combination of pathogens
was RSV + hRV (n = 23) followed by RSV + hBoV (n = 10) and RSV + AdV (n = 7) (see
Table 3). The virus most frequently found in dual infection was RSV (n = 42), followed by hRV
Table 2. Distribution of viral agents according to age in the GENDRES cohort (GEN) and UK cohort (UK). Data are presented as number of positive
samples (percentage of evaluated samples) or the mean (standard deviation). Age is expressed in months.







Age (months) [GEN n = 203; UK n = 97]
0–12 12–24 24–48 >48
GEN UK GEN UK GEN UK GEN UK GEN UK GEN UK GEN UK GEN UK
RSV 108 35 53 21 55 14 8.1 12.8 88 21 12 8 5 5 3 1
(52.9) (36.1) (55.8) (33.3) (59.8) (43.8) (14.9) (14.6) (64.7) (53.8) (48.0) (47.1) (19.2) (29.4) (18.8) (4.2)
Rhinovirus 68 24 17 11 51 13 14.4 40.9 44 7 9 5 11 6 3 6
(33.3) (24.7) (17.9) (17.5) (55.4) (40.6) (17.4) (46.3) (32.4) (17.9) (36.0) (29.4) (42.3) (35.3) (18.8) (25.0)
Bocavirus 48 19 6 3 42 16 22.5 31.9 21 4 10 8 13 4 4 3
(23.5) (19.6) (6.3) (4.8) (45.7) (50.0) (27.4) (35.8) (15.4) (10.3) (40.0) (47.1) (50.0) (23.5) (25.0) (12.5)
Adenovirus 39 9 4 3 35 6 21.4 51.2 15 2 11 1 9 3 4 3
(19.1) (9.3) (4.2) (4.8) (38.0) (18.8) (20.1) (48.9) (11.0) (5.1) (44.0) (5.9) (34.6) (17.6) (25.0) (12.5)
Metapneumovirus 27 4 9 2 18 2 16.8 48.5 18 1 3 1 5 1 1 1
(13.2) (4.1) (9.5) (3.2) (19.6) (6.3) (27.7) (57.2) (13.2) (2.6) (12.0) (5.9) (19.2) (5.9) (6.3) (4.2)
Inﬂuenza virus 12 23 4 13 8 10 35.7 45.9 2 5 4 5 4 5 2 8
(5.9) (23.7) (4.2) (20.6) (8.7) (31.3) (43.2) (44.0) (1.5) (12.8) (16.0) (29.4) (15.4) (29.4) (12.5) (33.3)
Parainﬂuenza 5 6 1 3 4 3 40.4 41.6 3 2 0 1 1 2 1 1
(2.5) (6.2) (1.1) (4.8) (4.3) (9.3) (53.5) (55.8) (2.2) (5.1) (0.0) (5.9) (3.8) (11.8) (6.3) (4.2)
Coronavirus 5 _ 1 _ 4 _ 25.3 _ 2 _ 0 _ 1 _ 1 _
(2.5) (1.1) (4.3) (23.5) (1.5) (0.0) (3.8) (6.3)
Co-infection 92 29 _ _ _ _ 15.1 25.6 53 8 16 10 18 6 4 4
(45.1) (29.9) (16.1) (25.1) (41.7) (23.5) (72.7) (66.7) (75.0) (35.3) (30.8) (21.1)
Total samples 204 97 95 56 92 29 16.7 36.6 136 39 25 17 26 17 16 24
(46.1) (57.7) (45.1) (29.9) (28.5) (44.6) (67.0) (40.2) (12.3) (17.5) (12.8) (17.5) (7.9) (24.7)
doi:10.1371/journal.pone.0136526.t002
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(n = 35) (Table 2). RSV was observed with the same frequency as a single infection (n = 53)
and as a co-infection agent (n = 55) (see Fig 1). However, hRV, IV, hBoV, AdV and hMPV
were more frequently found in co-infections (Fig 1).
UK cohort
The UK cohort included samples from 97 patients, with a median age of 20.0 (first quartile: 7.0,
third quartile: 48.7) months and a male-to-female ratio of 0.94. We identified at least one virus
in 85 (87.6%) samples; in 12 samples no virus was identified. A single virus was present in 56
(57.7%) patients, and two or more viruses in 29 (29.9%) children. The most commonly
detected virus was RSV (n = 35), followed by hRV (n = 24), IV (n = 23), hBoV (n = 19), AdV
(n = 9), HMPV (n = 4) and hPIV (n = 6) (Table 2). In the co-infected samples, the most fre-
quent combinations were RSV + hBoV and IV + hBoV (both n = 5). The viruses most fre-
quently found in dual infections were RSV and hBoV (both n = 12), followed by hRV (n = 9)
and IV (n = 8) (Table 3). hRV and IV were observed with similar frequencies in single infection
and co-infection (hRV n = 11 vs 13; IV n = 13 vs 10), while hBoV and AdV were more fre-
quently found as co-infections, and RSV was more commonly present as a single infection.
Age patterns of infection
We compared co-infection frequencies according to age groups. In both cohorts, co-infection
was found in all age groups. In the GENDRES cohort, there is a significant association between
age and co-infection: in children aged 12–24 months (72.7% of infected patients; see Fig 1) and
those aged 24–48 months (75.0% of infected patients; P-value = 0.001). In the UK cohort, there
was also a significant association age and co-infection in patients aged 12–24 months (73.3% of
the infected patients; P-value = 0.005).
In the GENDRES cohort, RSV infection affected younger children more frequently (mean
age: 8.1 months; SD: 14.9) and hPIV was principally found in older patients (mean age: 40.4
months; SD: 53.5) (Table 2). In the UK cohort, RSV infection also affected younger children
Table 3. Associations among respiratory pathogens in hospitalized children in the GENDRES and UK cohorts.
GENDRES cohort UK cohort
Pathogens detected Number % of positive cases Number % of positive cases
Co-infection, two pathogens 65 34.2 24 28.2
RSV+hRV/hBov/AdV/MPV/IV 23/10/7/2/0 12.3/5.3/3.7/1.1/0.0 3/4/2/0/2 3.5/4.7/2.4/0.0/2.4
hRV+hBov/hCov/AdV/MPV/IV/HPIV 2/2/6/3/0/0 0.5/1.1/3.2/1.6/0.0/0.0 3/0/1/1/1/1 3.5/0.0/1.2/1.2/1.2/1.2
IV+hBov/MPV 2/1 1.1/0.5 5/0 5.9/0.0
hBov+AdV/hCov/MPV 1/1/4 0.5/0.5/2.1 0/0/0 0.0/0.0/0.0
AdV+HPIV/MPV 1/1 0.5/0.5 1/0 1.2/0.0
Co-infection three pathogens 21 11.3 4 4.7
RSV+hRV+AdV/hBov/hCov 3/3/1 1.6/1.6/0.5 0/0/0 0.0/0.0/0.0
RSV+hBov+IV/AdV 2/4 0.5/1.1 0/1 0.0/1.2
hRV+hBov+AdV/IV 4/0 2.1/0.0 1/1 1.2/1.2
IV+hBov+AdV 2 1.1 1 1.2
hBov+MPV+AdV/HPIV 2/2 1.1/1.1 0/0 0.0/0.0/
Co-infection, four pathogens 6 3.2 1 1.2
hRV+hBov+AdV+IV/MPV/HPIV 1/3/1 0.5/1.6/0.5 0 0.0
hRV+hBov+MPV+HPIV/RSV 1/0 0.5/0.0 0/1 0/1.2
doi:10.1371/journal.pone.0136526.t003
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more frequently (mean age: 12.8 months; SD: 14.6) and AdV predominated in older patients
(mean age: 51.2 months; SD: 48.9).
PICU admission
There was no significant difference in the number of infections between the PICU and non-
PICU cohorts. Although modest differences were found for hBoV (PICU: 15.8%—non PICU:
22.6%) and hMPV (PICU: 2.6%—non PICU: 14.0%) in the GENDRES cohort, these were not
statistically significant. These differences were only observed in the UK cohort for hBoV
(PICU: 16.3%—non PICU: 22.2%) (Table 4).
Table 4. Virus detection in PICU admitted patients in both cohorts. No differences were found when compared to those children not requiring PICU
admission.
Virus GENDRES cohort UK cohort
PICU admission
(n = 38) n (%)
No PICU admission




(n = 43) n (%)
No PICU admission
(n = 54) n (%)
P-
value
RSV 24 (63.2) 56 (60.2) 0.844 17 (39.5) 18 (33.3) 0.671
Rhinovirus 15 (39.5) 28 (30.1) 0.312 11 (25.6) 13 (24.1) 1.000
Bocavirus 6 (15.8) 21 (22.6) 0.479 7 (16.3) 12 (22.2) 0.451
Adenovirus 5 (13.2) 14 (15.1) 1.000 3 (7.0) 6 (11.1) 0.727
Metapneumovirus 1 (2.6) 13 (14.0) 0.066 2 (4.7) 2 (3.7) 1.000
Inﬂuenza 1 (2.6) 4 (4.3) 1.000 8 (18.6) 15 (27.8) 0.342
Parainﬂuenza 1 (2.6) 3 (3.2) 1.000 1 (2.3) 5 (9.3) 0.223
Coronavirus 1 (2.6) 1 (1.1) 0.498 - - -
doi:10.1371/journal.pone.0136526.t004
Fig 1. Pathogen prevalence in the main and replication cohorts shown as number detected in nasopharyngeal samples considering the age of the
children.Only the more prevalent viruses are presented.
doi:10.1371/journal.pone.0136526.g001
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Discussion
Multiple viruses are detected in at least one third of children hospitalized with LT-ARI. This
rate reaches two thirds for patients in their second year of age.
With the introduction of molecular techniques, the detection of multiple co-infecting
viruses has become common [21], though the prevalence of each virus varies between studies.
Our results show that viral co-infection is frequent, particularly in children above one year of
age: children aged 12–24 months had the highest number of detected viruses, which may reflect
slower clearance (and perhaps increased pathogenicity) following primary infection by a virus,
and an immature immune system [3,22]. We observed that co-infection rates were lower in
older children in both cohorts, despite this group being prone to greater LT-ARI exposure
through increased participation in shared childcare groups. This finding is inconsistent with
two previous reports. In particular, Chorazy et al. [23] reported a non-significant increase in
co-infection in children aged 6–12 months, and co-infection decreased after one year with
increasing age. Peng et al. [24] reported that co-infection was more frequent in children
between 3–6 years of age.
At least one respiratory pathogen was detected in 91.7% of the enrolled patients in the Span-
ish cohort and 87.2% in the UK cohort. This finding is in the upper end of the reported range
in children (between 47% and 95%) [3,25,26]. Possible explanations for the wide differences in
detection rates found in the literature include: (i) heterogeneity in studied populations (includ-
ing genetic variability and predisposition), (ii) differences in respiratory symptoms at presenta-
tion (upper or lower respiratory symptoms), (iii) differences in the time of sampling, (iv)
number of respiratory pathogens tested, and (v) the kind of diagnostic tests used [3,22,25].
Many patients had multiple respiratory viruses: 45.1% in the GENDRES cohort, and 29.9% in
the UK cohort, which is again in the upper end of the reported range (17–41%) [3,27,28].
In 12 cases there was discordance between a negative PCR and a positive diagnostic pretest.
This could be due to the different time of sampling, and/or it might be due to false positives,
which are known to occur more frequently in rapid tests. We also found five negative samples
(2.5%) for both PCR and pretest tested pathogens. These differences might be explained by the
time and mode of collection of the samples. In some patients, the initial conventional viral test
was performed on hospital admission samples, whilst PCR was performed using samples
obtained after the patients were transferred to PICU and recruited for the study.
Some viruses were mainly present as co-infecting agents (hRV, IV, hBoV, AdV and hMPV)
and rarely found as single pathogens. As previously reported [3,29,30], RSV was the most fre-
quent pathogen in both cohorts, especially in younger children. The second virus most fre-
quently detected by PCR was hRV. The clinical significance of a positive hRV PCR assay has
been questioned, given that hRV has been detected in asymptomatic children even two weeks
after the clinical symptoms had disappeared [31,32]. However, hRV has been identified as sin-
gle pathogen in some ARIs in children [21]. In our study, hRV was found in one third of sam-
ples and as single pathogen in approximately 10% of the cases.
In the GENDRES cohort, infection by both RSV and hRV was the most common viral co-
infection detected, but in the UK cohort the most common viral co-infections were RSV
+ hBoV and IV + hBoV. These differences most likely reflect the fact that UK patients were
recruited during the 2009 pandemic influenza season, but they may also reflect local differences
in epidemiology and recruitment (including a higher proportion of PICU cases in the UK
cohort).
Bocavirus is a recently discovered virus that may cause ARIs, particularly in children, with
the highest frequency found in hospitalized infants. Our results indicate that hBoV is com-
monly detected in respiratory samples of young children with LT-ARI, in agreement with
Viral Co-Infections in Children with Respiratory Infections
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previous reports [33,34]. In our study, hBoV was the third most frequently identified virus in
the GENDRES cohort, after RSV and hRV, and the fourth in the UK cohort. Our detection
rates in both the GENDRES and UK cohorts (23.5% and 19.6%, respectively) are higher than
those in other published series, which have reported variable prevalence ranges of 1.5–19%.
Methodological factors may explain these differences: our cohorts included only hospitalized
children, whereas other studies included inpatients and outpatients [33,35]. hBoV was rarely
found as a single infecting agent: in most cases (87.5%) it was found together with other respi-
ratory viruses, as previously observed [34,36,37]. RSV, hRV, AdV and hMPV viruses were the
most frequently observed co-pathogens, as observed by other authors [38–40].
In young children, hMPV is an important cause of bronchiolitis, accounting for 5–15% of
all cases [4,41,42]. In our study we found 27 (13.2%) hMPV-positive samples in the GENDRES
cohort. Of these, 66.7% of hMPV were detected as a co-infection with another respiratory
virus, and 33.3% were found as a mono-infection. In the UK cohort four (4.1%) samples were
hMPV-positive, including two with co-infection. Co-infection with hMPV has been proposed
to increase disease severity in some studies [5,43,44], but not in others [45]. Dual infection
with RSV is reportedly common, reflecting the overlapping seasonal distributions. One study
reported that 70% of children with severe RSV bronchiolitis were co-infected with hMPV, sug-
gesting that the disease caused by RSV may be augmented by a concurrent hMPV infection
[44]. However, population-based and case control studies of hospitalized children have found
that hMPV and RSV co-infections are uncommon [42,43]. In our study, the low proportion of
mono-infected patients suggests that hMPV rarely produces clinically significant infection by
itself, but co-infection of hMPV with RSV was also uncommon (only two cases).
Bezerra et al. [46] have observed that AdV is frequently detected as part of a co-infection, in
contrast with the findings of Huang et al. [47]. AdV was reported to be responsible for 5–10%
of ARI in children [11]. Our detection rate ranged between 9.3% (UK cohort) and 19.1%
(GENDRES cohort) with a median age of 21.8 months.
Our study detected a broad range of common respiratory pathogens but it was not exhaus-
tive, and indeed it may have missed as yet undescribed respiratory pathogens. The study con-
sidered only children admitted with LT-ARI, and did not include milder or asymptomatic
infections. Several studies have shown that viruses can be found in children with no ARIs
[22,48], and further research is needed to understand the respiratory viral carriage and infec-
tion. Although quantification of the virus load by PCR is possible, respiratory samples are het-
erogeneous, and different extractions of the same patient can lead to diverse results depending
on chance variation in the amount of virus present in the aliquots extracted. Whilst the robust-
ness of our findings is supported by the broad similarity between the two independent cohorts
analyzed in the present study, its applicability to other populations is likely to be influenced by
local epidemiological and host genetic factors.
In conclusion, the presence of more than one virus in children admitted to hospital with
LT-AR ranged from one third to two thirds of these patients, depending on the age, and being
particularly frequent in the second year of age. The co-infection pattern most frequently found
was the combination of RSV and hRV. The clinical significance of co-infection remains diffi-
cult to establish from observational data. Further studies including also subjects with mild ill-
ness as well as healthy control groups are needed in order to better understand its clinical
relevance.
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